DENVER, June 26, 2017 /PRNewswire/ -- A global pharmaceutical sponsor recently deployed ClinOne after 12 months of initial low enrollment to accelerate enrollment rates across its actively recruiting sites. After just 30 days of deploying ClinOne, enrollment increased 41 percent compared to baseline and the higher enrollment rate continued until the sponsor attained complete enrollment, ahead of projections.
ClinOne's mobile technology provides active research sites with a continuous stream of engagement, access to clinical trial content and screening utility to increase enrollment. ClinOne's set-up time of under 30 days allowed the study to quickly benefit from its technologies and realized an enrollment gain within 20 days of launch.
ClinOne has expanded its technology offering to include the ability for referring physicians to quickly identify clinical trials for patients, screen patients using CT.gov screening criteria and easily refer the patients to an active research site for a specific study. Some sites may have as many as 500 potential referring physicians near their centers; the challenge historically was that research sites haven't been able to engage referring physicians efficiently or on a large scale. According to ClinOne's CEO Rob Bohacs — "we're just scratching the surface with building a global network of researchers and referring physicians to rapidly identifying patients for specific studies. We are completely changing the landscape for clinical trial enrollment."
ClinOne, based in Denver, Colorado, is a mobile technology company dedicated to transitioning research into a mobile environment to significantly improve how researchers and patients interact and engage with clinical trials. The company offers a full suite of mobile technologies to centralize research and deliver the needed clinical trial content to the right participants. ClinOne information platform aims to improve day-to-day engagement of clinicians, academic researchers, drug developers and patients to help advance drug and medical device clinical trials. For more information, please visit www.ClinOne.com.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-pharma-company-confirms-clinone-increased-our-patient-enrollment-by-41-percent-300479623.html
SOURCE ClinOne, Inc.